Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.

Taiga OtsukaYasunori KawaguchiToshihiko MizutaYasushi IdeFuta KogaTakanori KumagaiWataru YoshiokaKenichiro MurayamaOsamu RikitakeYuji IkedaIwata Ozaki

Published in: JGH open : an open access journal of gastroenterology and hepatology (2017)

Asunaprevir and daclatasvir could help patients with chronic hepatitis C receiving hemodialysis. Close collaboration with dialysis physicians is important when treating these patients because hemodialysis carries life-threatening risks.

Keyphrases

hepatitis c virus
end stage renal disease
chronic kidney disease
peritoneal dialysis
human immunodeficiency virus
primary care
ejection fraction
newly diagnosed
human health
patient reported outcomes